CytoDyn Panel Seeks To Reverse $14M Directors Award
A special litigation committee of the board of life sciences venture CytoDyn Inc. asked Delaware Chancery Court on Wednesday to approve a settlement requiring five directors to forfeit some or all of...To view the full article, register now.
Already a subscriber? Click here to view full article